Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1986 Mar;51(3):964–965. doi: 10.1128/iai.51.3.964-965.1986

Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease.

L D Gray, A S Kreger
PMCID: PMC260995  PMID: 3949387

Abstract

An enzyme-linked immunosorbent assay and a cytolysin neutralization assay were used detect anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human that survived V. vulnificus disease. The detection of antibodies against the cytolysin indicated that the cytolysin is produced in vivo, and this observation is consistent with the hypothesis that the cytolysin is involved in the pathogenesis of V. vulnificus disease.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blake P. A., Weaver R. E., Hollis D. G. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341–367. doi: 10.1146/annurev.mi.34.100180.002013. [DOI] [PubMed] [Google Scholar]
  2. Bowdre J. H., Poole M. D., Oliver J. D. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun. 1981 Jun;32(3):1193–1199. doi: 10.1128/iai.32.3.1193-1199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christensson B., Fehrenbach F. J., Hedström S. A. A new serological assay for Staphylococcus aureus infections: detection of IgG antibodies to S. aureus lipase with an enzyme-linked immunosorbent assay. J Infect Dis. 1985 Aug;152(2):286–292. doi: 10.1093/infdis/152.2.286. [DOI] [PubMed] [Google Scholar]
  4. Duncan J. L. Streptococcal growth and toxin production in vivo. Infect Immun. 1983 May;40(2):501–505. doi: 10.1128/iai.40.2.501-505.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gray L. D., Kreger A. S. Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect Immun. 1985 Apr;48(1):62–72. doi: 10.1128/iai.48.1.62-72.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jagger K. S., Robinson D. L., Franz M. N., Warren R. L. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. J Clin Microbiol. 1982 Jun;15(6):1054–1058. doi: 10.1128/jcm.15.6.1054-1058.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kreger A. S. Cytolytic activity and virulence of Vibrio damsela. Infect Immun. 1984 May;44(2):326–331. doi: 10.1128/iai.44.2.326-331.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kreger A. S., Gray L. D., Testa J. Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect Immun. 1984 Sep;45(3):537–543. doi: 10.1128/iai.45.3.537-543.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun. 1981 Aug;33(2):583–590. doi: 10.1128/iai.33.2.583-590.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morris J. G., Jr, Black R. E. Cholera and other vibrioses in the United States. N Engl J Med. 1985 Feb 7;312(6):343–350. doi: 10.1056/NEJM198502073120604. [DOI] [PubMed] [Google Scholar]
  11. Pollack M., Callahan L. T., 3rd, Taylor N. S. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun. 1976 Oct;14(4):942–947. doi: 10.1128/iai.14.4.942-947.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Poole M. D., Oliver J. D. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978 Apr;20(1):126–129. doi: 10.1128/iai.20.1.126-129.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ruiz-Palacios G. M., López-Vidal Y., Torres J., Torres N. Serum antibodies to heat-labile enterotoxin of Campylobacter jejuni. J Infect Dis. 1985 Aug;152(2):413–416. doi: 10.1093/infdis/152.2.413. [DOI] [PubMed] [Google Scholar]
  14. Tison D. L., Kelly M. T. Vibrio species of medical importance. Diagn Microbiol Infect Dis. 1984 Sep;2(4):263–276. doi: 10.1016/0732-8893(84)90057-9. [DOI] [PubMed] [Google Scholar]
  15. Wickboldt L. G., Sanders C. V. Vibrio vulnificus infection. Case report and update since 1970. J Am Acad Dermatol. 1983 Aug;9(2):243–251. doi: 10.1016/s0190-9622(83)80357-0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES